NUP188 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.940600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.383000E-01
Normal-vs-Stage2
6.193600E-01
Normal-vs-Stage3
1.096180E-01
Normal-vs-Stage4
4.511600E-01
Stage1-vs-Stage2
7.068200E-01
Stage1-vs-Stage3
1.282750E-01
Stage1-vs-Stage4
9.646200E-01
Stage2-vs-Stage3
7.767800E-02
Stage2-vs-Stage4
7.839800E-01
Stage3-vs-Stage4
1.048820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.000600E-01
Normal-vs-AfricanAmerican
6.610400E-01
Normal-vs-Asian
6.886600E-01
Caucasian-vs-AfricanAmerican
9.831600E-01
Caucasian-vs-Asian
8.926000E-01
AfricanAmerican-vs-Asian
9.465000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.799400E-01
Normal-vs-Female
7.258600E-01
Male-vs-Female
3.507000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.725000E-01
Normal-vs-Age(41-60Yrs)
9.350400E-01
Normal-vs-Age(61-80Yrs)
4.102000E-01
Normal-vs-Age(81-100Yrs)
4.598000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.362400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.263800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.604800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.775980E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.742500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.032800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.318200E-01
Normal-vs-Daily Drinker
2.770800E-01
Normal-vs-Weekly Drinker
8.797600E-01
Normal-vs-Occasional Drinker
6.853000E-01
Normal-vs-Social Drinker
8.450200E-01
Non Drinker-vs-Daily Drinker
8.531000E-01
Non Drinker-vs-Weekly Drinker
4.147400E-01
Non Drinker-vs-Occasional Drinker
3.221200E-01
Non Drinker-vs-Social Drinker
1.154180E-01
Daily Drinker-vs-Weekly Drinker
3.292400E-01
Daily Drinker-vs-Occasional Drinker
1.535010E-01
Daily Drinker-vs-Social Drinker
2.282000E-02
Weekly Drinker-vs-Occasional Drinker
8.844800E-01
Weekly Drinker-vs-Social Drinker
5.777600E-01
Occasional Drinker-vs-Social Drinker
2.855800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.145200E-01
Normal-vs-Grade 2
8.424800E-01
Normal-vs-Grade 3
8.630000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.589200E-01
Grade 1-vs-Grade 3
2.553600E-01
Grade 1-vs-Grade 4
8.145200E-01
Grade 2-vs-Grade 3
4.577000E-01
Grade 2-vs-Grade 4
8.424800E-01
Grade 3-vs-Grade 4
8.630000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.631600E-01
Normal-vs-NonDiabetic
6.171600E-01
Diabetic-vs-NonDiabetic
3.885600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.894000E-01
Normal-vs-NoPancreatitis
5.934400E-01
Pancreatitis-vs-NoPancreatitis
7.559200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.338800E-01
Normal-vs-N1
5.974400E-01
N0-vs-N1
7.678200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.826000E-01
Normal-vs-TP53-NonMutant
5.505800E-01
TP53-Mutant-vs-TP53-NonMutant
3.428000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
